Category Archives: Hepatitis Testing

Asia Times Online :: India backs costly drug mix

India backs costly drug mixBy Ranjit Devraj NEW DELHI – India’s Health Ministry this month ignored widespread concern over the safety, efficacy and cost of pentavalent vaccines and approved inclusion of the prophylactic cocktail in a universal immunization program in seven of its provinces. Pentavalent vaccine doses, a cocktail of five antigens in a single [...]

Posted in Hepatitis Testing | Tagged , , , , , , , , , | Comments closed

Medical officer questions need for blood-sample bill

B.C.’s provincial health officer is raising concerns about government legislation that, if passed, would allow emergency workers to compel blood samples from people when they are potentially exposed to a deadly illness.Dr. Perry Kendall said he believes there are better ways to deal with possible exposures – such as when a person bleeds into an [...]

Posted in Hepatitis Testing | Tagged , , , , , , , , | Comments closed

Broad-Spectrum Antivirals: The Future of HIV Treatment?

Could a single drug be used to treat a variety of viruses — potentially all viruses, including HIV? at least three novel approaches are being worked on to create such a drug, also known as a broad-spectrum antiviral.Broad-spectrum drugs already exist in other areas of medicine. For instance, we have antibiotics to treat a wide [...]

Posted in Hepatitis Testing | Tagged , , , , , , , , , | Comments closed

Biostar Pharmaceuticals, Inc. Announces 2012 First Quarter Financial Results

XIANYANG, China, may 15, 2012 /PRNewswire via COMTEX/ –Biostar Pharmaceuticals, Inc. /quotes/zigman/9453669/quotes/nls/bspm BSPM +4.00% (“Biostar” or “the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial results for the first quarter ended March 31, 2012. first Quarter 2012 vs. [...]

Posted in Hepatitis Testing | Tagged , , , , , , , , , | Comments closed

Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate

LA JOLLA, Calif., April 23, 2012 /PRNewswire/ – Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that the Japan Patent Office has issued a decision to Grant a Patent in the ‘Sarnow’ patent series for microRNA-122 (miR-122) therapy in the treatment of chronic hepatitis C virus [...]

Posted in Hepatitis Testing | Tagged , , , , , , , , , | Comments closed